lobbying_activities: 2104891

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2104891	2c54eed7-2c49-44e2-9f4a-2885b9f1d21d	Q1	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2018	first_quarter	MMM	Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PBM transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 4392, nullfying a rule finalized by the Centers for Medicare & Medicaid Services that modifies payment under Medicare for certain drugs purchased through the 340B discount program.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		200000	0	0	2018-04-12T12:54:34.977000-04:00